Popular Articles

IDRI Makes Its Adjuvant Available To Increase Global Supply Of Pandemic Vaccines
Following the World Health Organization (WHO) declaration of swine flu pandemic, the Infectious Disease Research Institute (IDRI) announced it has successfully developed an adjuvant that could significantly enhance both the effectiveness and supplies of pandemic flu vaccines. The Seattle-based not-for-profit organization will make its adjuvant technology available to flu vaccine manufacturers for the production of A (H1N1) or future pandemic flu vaccines.
generic viagra online
DOD, VA, Congress Should Take Stronger Steps Toward Eliminating Tobacco Use In Military Populations, VA Medical Centers
Because tobacco use impairs military readiness, harms the health of soldiers and veterans, and imposes a substantial financial burden on the departments of Defense and Veterans Affairs, these agencies should implement a comprehensive strategy to achieve the Defense Department"s stated goal of a tobacco-free military, says a new report from the Institute of Medicine. DOD should gradually phase in a ban on tobacco use in the military, starting at military academies and officer training programs and among new recruits, the report says. DOD should also stop selling tobacco products in Army and Air Force commissaries -- Navy and Marine Corps commissaries already do not sell them -- and should stop selling them at a discount in military exchanges and other stores. In addition, Congress should allow VA to establish tobacco-free medical centers.
News of the day
Swine Flu Update Issued On Monday 29 June 2009, Wales
-- 17 confirmed cases in Wales, with 0 new cases.
Diagnostics

APhA Publishes New Print, CD-ROM Editions Of Handbook Of Pharmaceutical Excipients

The American Pharmacists Association (APhA) will publish this month the sixth edition of Handbook of Pharmaceutical Excipients and the corresponding single-user CD ROM, titled Pharmaceutical Excipients 6. Written by approximately 150 pharmaceutical scientists from around the world who are expert in pharmaceutical formulation or excipients manufacture, the new editions contain 340 fully referenced monographs on the most commonly used excipients in pharmaceutical dosage formulation. Forty monographs are new and all the monographs from the fifth edition have been completely revised and updated, many including NIR spectra. The 40 monographs new to this edition include glycine, hydroxypropyl betadex, methionine, neotame, pentetic acid, poly(DL-lactic acid), and tagatose. Each monograph consists of 22 categories of information: nonproprietary names, synonyms, chemical name and CAS registry number, empirical formula and molecular weight, structural formula, functional category, applications in pharmaceutical formulation or technology, description, pharmacopeial specifications, typical properties, stability and storage conditions, incompatibilities, method of manufacture, safety, handling precautions, regulatory status, related substances, comments, specific references, general references, author, and date of revision. Monographs are cross referenced and indexed so that excipients may be identified by chemical, nonproprietary, or trade names. Scanning electron microphotographs are included for many of the excipients. An appendix includes an expanded, completely updated list of worldwide suppliers of excipients that is organized alphabetically and geographically. Pharmaceutical Excipients 6 (single-user CD ROM) includes the complete text of 340 monographs with graphics. Other features: custom-written user interface; full text searching; hot-linked contents list, index, and suppliers" directory; copy and paste and printing facility. Pharmaceutical Excipients is also available online through MedicinesComplete. Trial and annual licenses are available for individuals, groups, or organizations. Pricing information is available from Sales@MedicinesComplete.com. The excipients references, published jointly by APhA and the Pharmaceutical Press, the publications department of the Royal Pharmaceutical Society of Great Britain, London, United Kingdom, are edited by Raymond C. Rowe, PhD, Paul J. Sheskey, BPharm, and Marian E. Quinn, MS. Rowe is Chief Scientist, Intelligensys Ltd., Stokesley, North Yorkshire, UK, and Professor of Industrial Pharmaceutics, School of Pharmacy, University of Bradford, UK; Sheskey is Application Development Leader in the Dow-Wolff Cellulosics R&D Group at The Dow Chemical Company, Midland, Michigan; and Quinn is Development Editor, The Pharmaceutical Press, London, UK. The regular price for the book (ISBN 978-1-135-2; 888 pages, hardbound) or CD ROM (978-1-58212-136-9) is $399.95 ($359.95 for APhA members). The book and CD-ROM are available as a package (ISBN 978-1-58212-137-6) for $599.95 ($539.95 for APhA members). Until August 31 prices are discounted, with the book or CD ROM selling for $375 ($337.50 for APhA members) and the book-CD ROM package selling for $550 ($495 for APhA members). Orders may be made through APhA"s toll-free order department (800-878-0729) or online via http://www.pharmacist.com. To obtain the discount through August 31, purchasers should use offer code D9005. American Pharmacists Association (APhA)


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):